https://www.selleckchem.com/pr....oducts/Gemcitabine-H
Outcomes were evaluated using scattered plot and Kaplan-Meier survival curve. RESULTS 21 eyes (70%) and 28 eyes (93.3%) achieved complete and partial success at one year, respectively. There was a significant reduction of IOP (28.5±9.6 to 15.5±2.6▒mmHg, P less then 0.001) and medication use (4.4±0.9 to 0.8±1.2 bottle per eye, P less then 0.001). There were no significant changes in BCVA, VCDR, and VF indices. No wound leak was identified throughout the study. The procedure did not induce significant astigmatic
Like
Comment
Share
